Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DYNARESOURCE, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
9.5
10.9
14.1
11.6
9.05
35.9
39.8
35.6
46.5
58.5
Gross profit
-1.4
17.3
General and administrative
2.78
2.61
2.2
2.05
2.97
3.77
4.13
8.53
4.16
6.19
Operating expenses
7.98
11.5
16.6
13.3
11.7
22.7
37
50.8
5.54
7.61
Operating income
1.52
-0.63
-2.53
-1.65
-2.68
13.2
2.77
-15.2
-6.94
9.67
Interest expense
1.57
0.45
0.57
1.7
1.61
Other non-operating income
-0.02
3.16
1.57
0.79
-2.69
-4.62
1.34
-0.24
-1.25
-0.47
Pre-tax income
1.5
2.53
-0.97
-0.86
-5.37
8.56
4.11
-15.5
-8.18
9.19
Income tax
0
0
0
0
0
0.03
-2.58
-0.93
0.34
5.38
Net income to minority interests
0.35
0.13
0.38
0.06
0.06
Net income
1.5
2.53
-0.97
-0.86
-5.37
8.53
6.69
-14.5
-8.52
3.82
EBITDA
1.59
-0.47
-2.53
-1.65
-2.68
13.2
2.77
-15.2
-6.9
10.7
EPS, basic
0.10
0.15
-0.04
-0.05
-0.31
0.47
0.33
-0.65
-0.35
0.12
EPS, diluted
0.10
0.14
-0.04
-0.05
-0.31
0.47
0.29
-0.65
-0.35
0.13
Shares, basic (weighted)
16.7
17.1
17.7
17.7
17.7
17.8
19.5
22.7
24.7
29.3
Shares, diluted (weighted)
18.6
18.9
17.7
17.7
17.7
17.8
22.9
22.7
24.7
37.9
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
2.2
3.53
2.69
0.35
1.5
15.7
0
0
0
0
Receivables
0.72
0.88
1.21
0
Inventory
0.56
0.91
1.59
0.52
0.6
2.72
2.72
2.09
1.58
1.6
Other current assets
0.07
0.04
0.37
0.34
0.58
0.67
1.15
1.14
0.66
0.69
Total current assets
4.37
5.53
6.57
3.62
6.82
23.8
33.1
14.1
12.2
10.2
Property, plant and equipment
0.58
1.7
0.01
0.01
0.01
0
0
0.1
0.08
5.23
Lease right-of-use assets
0
0.81
0.74
0.65
0.55
0.85
0.73
0.5
Total assets
9.17
11.5
10.9
8.74
11.9
28.8
40.9
35.4
38.5
57.6
Accounts payable
0.85
0.8
1.07
2.06
2.27
1.28
2.06
2.77
4.89
11.6
Accrued liabilities
1.37
2.06
2.78
1.78
3.39
5.44
5.76
7.73
9.86
Short-term debt
0.96
0.95
0.71
1.64
1.98
1.96
Total current liabilities
8.51
7.36
8.35
6.97
12.6
22.5
21.3
24.4
30.5
41.9
Long-term debt
0
0.24
1.1
0.63
0.1
0
0
6.67
Lease liabilities
0
0.77
0.69
0.59
0.56
0.83
0.7
0.51
Other non-current liabilities
0
0.27
Total liabilities
8.51
7.59
9.45
9.14
17.2
23.1
21.9
25.8
31.8
52.8
Total debt
0.96
1.19
1.8
2.27
2.08
1.96
Paid-in capital
55.1
56.6
56.6
56.6
50.4
50.6
56.9
61.5
69.1
70.2
Retained earnings
-53.6
-50.9
-53.2
-54
-59.3
-50.7
-44
-58.6
-69.2
-65.4
Treasury stock
3.18
2.22
-2.22
-2.22
-1.47
-0.03
0
-0.1
0
-0.1
Other comprehensive income
3.77
1.27
1.25
0.33
0.44
-0.25
0.11
0.7
-1.79
-8.65
Shareholders' equity
2.34
4.98
2.71
-4.73
-9.67
-0.15
13.2
1.74
1.02
-1.09
Minority interests
-6.01
-5.43
-5.61
5.72
0
Total equity
-3.68
-2.11
-2.9
-4.73
-9.67
-0.15
13.2
1.74
1.02
-1.09
Total liabilities and equity
9.17
11.5
10.9
8.74
11.9
28.8
40.9
35.4
38.5
57.6
Shares outstanding
16.7
17.7
17.7
17.7
17.7
18.1
22.2
23.4
23.4
30.1
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
1.5
2.53
-0.97
-0.86
-5.37
-8.53
6.69
14.5
-8.13
3.82
Depreciation and amortization
0.08
0.15
0.01
0
0
0
0
0.01
0.03
1
Stock-based compensation
0.88
0.88
1.22
1.25
Deferred income tax
-0.44
0
0
-2.97
-0.61
-0.55
3.59
Change in receivables
-0.37
0.13
-0.75
-0.03
-0.26
0.26
-0.15
-0.16
-0.33
1.21
Change in inventory
-0.53
-0.35
-0.68
1.07
0.08
-1.51
-0.61
0.63
0.23
-1.23
Change in payables
0.06
-0.05
1.48
0.99
0.21
-1
0.78
0.71
2.93
8.18
Cash from operations
0.54
2.06
-0.53
-1.32
-2.42
17.5
-1.78
-17.7
-8.01
5.76
Capital expenditures
-0.15
-1.27
-0
0
0
0
-0.12
-0.01
-2.61
Cash from investing
-0.15
-1.27
0.02
0
0
-0.12
-0.01
-11.5
Debt issued
0
12
Debt repaid
0
-0.17
-0.4
-0.11
-0.07
-0.06
-0.09
Stock issued
0
2.5
0
0
5
6
0
Dividends paid
-0.16
0
-0.17
-0.19
Cash from financing
-0.31
2.33
-0.51
-0.11
3.59
-2.56
4.78
3.67
8.5
5.06
Exchange rate effect
0.19
-1.78
0.18
-0.9
-0.02
-0.74
0.46
0.53
-1.3
0.1
Net change in cash
0.27
1.33
-0.84
-2.33
1.15
14.2
3.46
-13.6
-0.82
-0.61
Free cash flow
0.39
0.79
-0.54
-1.32
-2.42
-1.78
-17.8
-8.02
3.14
Interest paid
0.12
0.16
0.4
0.2
0.21
0.58
0.06
0
0.96
1.72
Income taxes paid
0
0
0
0
0
0
0.03
0.2
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.88 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
28.5%
Gross profit / revenue.
Operating margin
15.7%
Operating income / revenue.
EBITDA margin
17.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
18.9%
Pre-tax income / revenue.
Net margin
10.1%
Net income / revenue.
FCF margin
7.6%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
11.1%
Cash from operations / revenue.
Effective tax rate
46.6%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
138.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
9.5%
Net income / average total assets.
Return on invested capital (ROIC)
115.5%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
2.1%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
3.5%
Capital expenditures / revenue.
D&A / revenue
2.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
25.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
13.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
45.2%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y
51.7%
Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 3y
56.7%
Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 3y
-17.0%
Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 3y
-23.5%
Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-207.5%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
49.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
12.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
37.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
53.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
18.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
16.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.15x
Current assets / current liabilities.
Quick ratio
0.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
31.7%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.16
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.55
Revenue / diluted weighted shares.
FCF per share
$0.12
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.17
Cash from operations / diluted weighted shares.
Book value per share
$0.14
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
4.52x
Market cap / net income. Only when net income is positive.
P/S
0.45x
Market cap / revenue.
P/B
6.26x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
6.26x
Market cap / tangible book value, when positive.
P/FCF
6.00x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
4.10x
Market cap / cash from operations, when positive.
EV/Sales
0.45x
Enterprise value / revenue.
EV/EBIT
2.89x
Enterprise value / operating income, when both are positive.
EV/EBITDA
2.54x
Enterprise value / EBITDA, when both are positive.
EV/FCF
6.00x
Enterprise value / free cash flow, when both are positive.
FCF yield
16.7%
Free cash flow / market cap.
Earnings yield
22.1%
Net income / market cap (the inverse of P/E).
What was DYNARESOURCE, INC.'s revenue in fiscal 2025?
DYNARESOURCE, INC. reported revenue of $58.5M for fiscal 2025, 25.7% higher than the year before.
Was DYNARESOURCE, INC. profitable in fiscal 2025?
Yes. Net income was $3.8M, a net margin of 6.5%.
How much free cash flow did DYNARESOURCE, INC. generate in fiscal 2025?
Cash from operations of $5.8M minus capital expenditures of $2.6M left free cash flow of $3.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.